Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Condition: Graft vs Host Disease
Interventions: Biological: Begelomab; Biological: Conventional Second-line Treatment
Sponsors: Adienne SA; ADIENNE S.r.l. S.U.
Recruiting - verified October 2016
Interventions: Biological: Begelomab; Biological: Conventional Second-line Treatment
Sponsors: Adienne SA; ADIENNE S.r.l. S.U.
Recruiting - verified October 2016